The new facility will focus on Merck’s leading brands referenced in China’s essential drug list and serve the country’s expanding healthcare needs in the areas of diabetes, cardiovascular diseases and thyroid disorders
China Bio news release, November 15, 2013
Merck-Serono builds pharmaceutical production base in Nantong Development Zone, Jiangsu Province, 80 million € investment